BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boccara F, Mary-Krause M, Teiger E, Lang S, Lim P, Wahbi K, Beygui F, Milleron O, Gabriel Steg P, Funck-Brentano C. Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis. Eur Heart J. 2011;32:41-50. [PMID: 20965887 DOI: 10.1093/eurheartj/ehq372] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Escárcega RO, Franco JJ, Mani BC, Vyas A, Tedaldi EM, Bove AA. Cardiovascular disease in patients with chronic human immunodeficiency virus infection. International Journal of Cardiology 2014;175:1-7. [DOI: 10.1016/j.ijcard.2014.04.155] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
2 Schafer JJ, Gill TK, Sherman EM, McNicholl IR. ASHP Guidelines on Pharmacist Involvement in HIV Care. Am J Health Syst Pharm 2016;73:468-94. [PMID: 26892679 DOI: 10.2146/ajhp150623] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
3 Lang S, Mary-Krause M, Simon A, Partisani M, Gilquin J, Cotte L, Boccara F, Costagliola D. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clin Infect Dis. 2012;55:600-607. [PMID: 22610928 DOI: 10.1093/cid/cis489] [Cited by in Crossref: 105] [Cited by in F6Publishing: 101] [Article Influence: 10.5] [Reference Citation Analysis]
4 Boccara F. Cardiovascular health in an aging HIV population. AIDS 2017;31 Suppl 2:S157-63. [PMID: 28471946 DOI: 10.1097/QAD.0000000000001384] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
5 Ebner B, Vincent L, Grant J, Martinez C. Cardiac Catheterization Procedures in Patients with HIV: A Retrospective Analysis. J Cardiovasc Dev Dis 2021;8:33. [PMID: 33801600 DOI: 10.3390/jcdd8040033] [Reference Citation Analysis]
6 Seecheran VK, Giddings SL, Seecheran NA. Acute coronary syndromes in patients with HIV. Coron Artery Dis 2017;28:166-72. [PMID: 27845996 DOI: 10.1097/MCA.0000000000000450] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
7 Boccara F, Lang S, Meuleman C, Ederhy S, Mary-Krause M, Costagliola D, Capeau J, Cohen A. HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol. 2013;61:511-523. [PMID: 23369416 DOI: 10.1016/j.jacc.2012.06.063] [Cited by in Crossref: 181] [Cited by in F6Publishing: 167] [Article Influence: 20.1] [Reference Citation Analysis]
8 Hauguel-Moreau M, Boccara F, Boyd A, Salem JE, Brugier D, Curjol A, Hulot JS, Kerneis M, Galier S, Cohen A, Montalescot G, Collet JP, Silvain J. Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV study. Eur Heart J 2017;38:1676-86. [PMID: 28065907 DOI: 10.1093/eurheartj/ehw583] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
9 Boccara F, Mary-Krause M, Potard V, Teiger E, Lang S, Hammoudi N, Chauvet M, Ederhy S, Dufour-Soulat L, Ancedy Y, Nhan P, Adavane S, Steg PG, Funck-Brentano C, Costagliola D, Cohen A; PACS‐HIV (Prognosis of Acute Coronary Syndrome in HIV‐Infected Patients) Investigators †. HIV Infection and Long-Term Residual Cardiovascular Risk After Acute Coronary Syndrome. J Am Heart Assoc 2020;9:e017578. [PMID: 32844734 DOI: 10.1161/JAHA.119.017578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Liu Y, Chen Y, Hao Y, Xiao J, Li B, Zhang L, Han J, Zhao H, Nguyen TN. Assessment of Clinical Features in HIV-Infected Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in China. Journal of Interventional Cardiology 2022;2022:1-8. [DOI: 10.1155/2022/8351304] [Reference Citation Analysis]
11 Sinha A, Feinstein MJ. Coronary Artery Disease Manifestations in HIV: What, How, and Why. Can J Cardiol 2019;35:270-9. [PMID: 30825949 DOI: 10.1016/j.cjca.2018.11.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
12 Ekun OA, Fasela EO, Oladele DA, Liboro GO, Raheem TY. Risks of cardio-vascular diseases among highly active antiretroviral therapy (HAART) treated HIV seropositive volunteers at a treatment centre in Lagos, Nigeria. Pan Afr Med J 2021;38:206. [PMID: 33995812 DOI: 10.11604/pamj.2021.38.206.26791] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Bloomfield GS, Hogan JW, Keter A, Holland TL, Sang E, Kimaiyo S, Velazquez EJ. Blood pressure level impacts risk of death among HIV seropositive adults in Kenya: a retrospective analysis of electronic health records. BMC Infect Dis 2014;14:284. [PMID: 24886474 DOI: 10.1186/1471-2334-14-284] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
14 Bundhun PK, Pursun M, Huang WQ. Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis. BMC Cardiovasc Disord 2017;17:190. [PMID: 28716008 DOI: 10.1186/s12872-017-0624-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
15 Peyracchia M, De Lio G, Montrucchio C, Omedè P, d'Ettore G, Calcagno A, Vullo V, Cerrato E, Pennacchi M, Sardella G, Manga P, GrossoMarra W, Vullo F, Fedele F, Biondi-Zoccai G, Moretti C, Vachiat A, Bonora S, Rinaldi M, Mancone M, D'Ascenzo F. Evaluation of coronary features of HIV patients presenting with ACS: The CUORE, a multicenter study. Atherosclerosis 2018;274:218-26. [PMID: 29803160 DOI: 10.1016/j.atherosclerosis.2018.05.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
16 Neves JS, Guerreiro V, Carvalho D, Serrão R, Sarmento A, Freitas P. Metabolically Healthy or Metabolically Unhealthy Obese HIV-Infected Patients: Mostly a Matter of Age? Front Endocrinol (Lausanne) 2018;9:681. [PMID: 30505292 DOI: 10.3389/fendo.2018.00681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Mavroudis CA, Majumder B, Loizides S, Christophides T, Johnson M, Rakhit RD. Coronary artery disease and HIV; getting to the HAART of the matter. International Journal of Cardiology 2013;167:1147-53. [DOI: 10.1016/j.ijcard.2012.09.043] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
18 Volpe M, Uglietti A, Castagna A, Mussini C, Marchetti G, Bellagamba R, Bini T, Mancusi D, Termini R. Cardiovascular disease in women with HIV-1 infection. Int J Cardiol 2017;241:50-6. [PMID: 28285796 DOI: 10.1016/j.ijcard.2017.02.117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
19 Rasmussen LD, Helleberg M, May MT, Afzal S, Kronborg G, Larsen CS, Pedersen C, Gerstoft J, Nordestgaard BG, Obel N. Myocardial infarction among Danish HIV-infected individuals: population-attributable fractions associated with smoking. Clin Infect Dis 2015;60:1415-23. [PMID: 25595744 DOI: 10.1093/cid/civ013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 53] [Article Influence: 2.4] [Reference Citation Analysis]
20 Ng B, Macpherson P, Haddad T, Dwivedi G. Heart failure in HIV infection: focus on the role of atherosclerosis. Current Opinion in Cardiology 2014;29:174-9. [DOI: 10.1097/hco.0000000000000041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
21 Mondal P, Aljizeeri A, Small G, Malhotra S, Harikrishnan P, Affandi JS, Buechel RR, Dwivedi G, Al-Mallah MH, Jain D. Coronary artery disease in patients with human immunodeficiency virus infection. J Nucl Cardiol 2021;28:510-30. [PMID: 32820424 DOI: 10.1007/s12350-020-02280-4] [Reference Citation Analysis]
22 Bagchi S, Burrowes SA, Fantry LE, Hossain MB, Tollera GH, Kottilil S, Pauza CD, Miller M, Baumgarten M, Redfield RR. Factors associated with high cardiovascular risk in a primarily African American, urban HIV-infected population. SAGE Open Med 2017;5:2050312117725644. [PMID: 28839941 DOI: 10.1177/2050312117725644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Nadel J, Holloway CJ. Screening and risk assessment for coronary artery disease in HIV infection: an unmet need. HIV Med 2017;18:292-9. [PMID: 27553248 DOI: 10.1111/hiv.12422] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
24 Bloomfield GS, Leung C. Cardiac Disease Associated with Human Immunodeficiency Virus Infection. Cardiol Clin 2017;35:59-70. [PMID: 27886790 DOI: 10.1016/j.ccl.2016.09.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
25 Nadel J, O'Dwyer E, Emmanuel S, Huang J, Cheruvu S, Sammel N, Brew B, Otton J, Holloway CJ. High-risk coronary plaque, invasive coronary procedures, and cardiac events among HIV-positive individuals and matched controls. J Cardiovasc Comput Tomogr 2016;10:391-7. [PMID: 27519655 DOI: 10.1016/j.jcct.2016.07.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
26 O'Brien MP, Zafar MU, Rodriguez JC, Okoroafor I, Heyison A, Cavanagh K, Rodriguez-Caprio G, Weinberg A, Escolar G, Aberg JA, Badimon JJ. Targeting thrombogenicity and inflammation in chronic HIV infection. Sci Adv 2019;5:eaav5463. [PMID: 31206016 DOI: 10.1126/sciadv.aav5463] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
27 Cerrato E, Calcagno A, D'Ascenzo F, Biondi-Zoccai G, Mancone M, Grosso Marra W, Demarie D, Omedè P, Abbate A, Bonora S, DiNicolantonio JJ, Estrada V, Escaned J, Moretti C, Gaita F. Cardiovascular disease in HIV patients: from bench to bedside and backwards. Open Heart 2015;2:e000174. [PMID: 25815207 DOI: 10.1136/openhrt-2014-000174] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 7.1] [Reference Citation Analysis]
28 Hatleberg CI, Ryom L, El-Sadr W, Smith C, Weber R, Reiss P, Fontas E, Dabis F, Law M, Monforte Ad, De Wit S, Mocroft A, Phillips A, Lundgren JD, Sabin C; D:A:D Study Group. Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals. AIDS 2016;30:1583-96. [PMID: 26950315 DOI: 10.1097/QAD.0000000000001076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
29 Lorgis L, Cottenet J, Molins G, Benzenine E, Zeller M, Aube H, Touzery C, Hamblin J, Gudjoncik A, Cottin Y, Quantin C. Outcomes After Acute Myocardial Infarction in HIV-Infected Patients: Analysis of Data From a French Nationwide Hospital Medical Information Database. Circulation 2013;127:1767-74. [DOI: 10.1161/circulationaha.113.001874] [Cited by in Crossref: 85] [Cited by in F6Publishing: 35] [Article Influence: 9.4] [Reference Citation Analysis]
30 Vallabhajosyula S, Subramaniam AV, Sundaragiri PR, Cheungpasitporn W, Temesgen Z, O'Horo JC, Jaffe AS, Barsness GW. Influence of Human Immunodeficiency Virus Infection on the Management and Outcomes of Acute Myocardial Infarction With Cardiogenic Shock. J Acquir Immune Defic Syndr 2020;85:331-9. [PMID: 32740372 DOI: 10.1097/QAI.0000000000002442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Boccara F, Cohen A. HIV and Heart Disease: What Cardiologists Should Know. Rev Esp Cardiol (Engl Ed) 2016;69:1126-30. [PMID: 27553286 DOI: 10.1016/j.rec.2016.05.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
32 Giugliano RP, Braunwald E. The Year in Non–ST-Segment Elevation Acute Coronary Syndrome. Journal of the American College of Cardiology 2011;58:2342-54. [DOI: 10.1016/j.jacc.2011.08.042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
33 Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, Grinspoon SK, Levin J, Longenecker CT, Post WS. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation 2019;140:e98-e124. [PMID: 31154814 DOI: 10.1161/CIR.0000000000000695] [Cited by in Crossref: 123] [Cited by in F6Publishing: 66] [Article Influence: 41.0] [Reference Citation Analysis]
34 Perelló R, Calvo M, Miró O, Castañeda M, Saubí N, Camón S, Foix A, Gatell JM, Masotti M, Mallolas J, Sánchez M, Martinez E. Clinical presentation of acute coronary syndrome in HIV infected adults: a retrospective analysis of a prospectively collected cohort. Eur J Intern Med 2011;22:485-8. [PMID: 21925057 DOI: 10.1016/j.ejim.2011.02.017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
35 Robert R, Cottin Y, Potard V, Mary-Krause M, Lang S, Teiger E, Collet JP, Chauvet-Droit M, Ederhy S, Soulat-Dufour L, Ancedy Y, Adavane-Scheuble S, Nhan P, Steg PG, Funck-Brentano C, Costagliola D, Cohen A, Boccara F; on behalf the PACS-HIV Investigators. Coronary Angiographic Features and Major Adverse Cardiac or Cerebrovascular Events in People Living With Human Immunodeficiency Virus Presenting With Acute Coronary Syndrome. Circ Cardiovasc Interv 2022;15:e011945. [PMID: 35535605 DOI: 10.1161/CIRCINTERVENTIONS.122.011945] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Jabłonowska E, Pulik P, Kalinowska A, Gąsiorowski J, Parczewski M, Bociąga-Jasik M, Pulik Ł, Siwak E, Wójcik K. Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients. J Med Virol 2017;89:2122-9. [PMID: 28390164 DOI: 10.1002/jmv.24826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
37 Albaeni A, Harris C, Eid SM, Abougergi MS, Wright SM. HIV status and type of coronary stent placed in patients presenting with ST-elevation myocardial infarction. Coron Artery Dis 2017;28:239-45. [PMID: 28288008 DOI: 10.1097/MCA.0000000000000488] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
38 Badr S, Minha S, Kitabata H, Fatemi O, Torguson R, Suddath WO, Satler LF, Pichard AD, Waksman R. Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus: PCI in Patients with HIV. Cathet Cardiovasc Intervent 2015;85:192-8. [DOI: 10.1002/ccd.25466] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
39 Schneider S, Spinner CD, Cassese S, Promny D, Hapfelmeier A, Byrne RA, Baumann M, Jäger H, Steinlechner E, Laugwitz KL, Kastrati A. Association of increased CD8+ and persisting C-reactive protein levels with restenosis in HIV patients after coronary stenting. AIDS 2016;30:1413-21. [PMID: 26891035 DOI: 10.1097/QAD.0000000000001063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
40 Parks MM, Secemsky EA, Yeh RW, Shen C, Choi E, Kazi DS, Hsue PY. Longitudinal management and outcomes of acute coronary syndrome in persons living with HIV infection. Eur Heart J Qual Care Clin Outcomes 2021;7:273-9. [PMID: 33226071 DOI: 10.1093/ehjqcco/qcaa088] [Reference Citation Analysis]
41 Lambert CT, Sandesara PB, Hirsh B, Shaw LJ, Lewis W, Quyyumi AA, Schinazi RF, Post WS, Sperling L. HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review. HIV Med 2016;17:411-24. [PMID: 26611380 DOI: 10.1111/hiv.12346] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
42 Feinstein MJ, Nance RM, Delaney JAC, Heckbert SR, Budoff MJ, Drozd DR, Burkholder GA, Willig JH, Mugavero MJ, Mathews WC, Moore RD, Eron JJ, Napravnik S, Hunt PW, Geng E, Hsue P, Peter I, Lober WB, Crothers K, Grunfeld C, Saag MS, Kitahata MM, Lloyd-Jones DM, Crane HM. Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS). BMC Med 2019;17:149. [PMID: 31362721 DOI: 10.1186/s12916-019-1385-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
43 Behrens GM. Abacavir and myocardial infarctions: the benefit of doubt? AIDS 2011;25:2043-5. [PMID: 21997489 DOI: 10.1097/QAD.0b013e32834bab9e] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
44 Raggio G, Goodman G, Robbins GK, Looby SE, Labbe A, Psaros C. Developing a pilot lifestyle intervention to prevent cardiovascular disease in midlife women with HIV. HIV Res Clin Pract 2021;22:1-13. [PMID: 33616022 DOI: 10.1080/25787489.2021.1883957] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Feinstein MJ, Poole B, Engel Gonzalez P, Pawlowski AE, Schneider D, Provias TS, Palella FJ, Achenbach CJ, Lloyd-Jones DM. Differences by HIV serostatus in coronary artery disease severity and likelihood of percutaneous coronary intervention following stress testing. J Nucl Cardiol 2018;25:872-83. [PMID: 27739037 DOI: 10.1007/s12350-016-0689-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
46 Boccara F. Acute coronary syndrome in HIV-infected patients. Does it differ from that in the general population? Arch Cardiovasc Dis 2010;103:567-9. [PMID: 21147440 DOI: 10.1016/j.acvd.2010.10.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
47 Charbit B, Gayat E, Voiriot P, Boccara F, Girard P, Funck-brentano C. Effects of HIV Protease Inhibitors on Cardiac Conduction Velocity in Unselected HIV-Infected Patients. Clin Pharmacol Ther 2011;90:442-8. [DOI: 10.1038/clpt.2011.131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
48 Mongardon N, Geri G, Deye N, Sonneville R, Boissier F, Perbet S, Camous L, Lemiale V, Thirion M, Mathonnet A, Argaud L, Bodson L, Gaudry S, Kimmoun A, Legriel S, Lerolle N, Luis D, Luyt CE, Mayaux J, Guidet B, Pène F, Mira JP, Cariou A. Etiologies, clinical features and outcome of cardiac arrest in HIV-infected patients. Int J Cardiol 2015;201:302-7. [PMID: 26301665 DOI: 10.1016/j.ijcard.2015.08.055] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
49 Tsabedze N, Vachiat A, Zachariah D, Manga P. A New Face of Cardiac Emergencies: Human Immunodeficiency Virus-Related Cardiac Disease. Cardiol Clin 2018;36:161-70. [PMID: 29173676 DOI: 10.1016/j.ccl.2017.09.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
50 Boccara F, Cohen A. VIH y cardiopatía: ¿qué deben saber los cardiólogos? Revista Española de Cardiología 2016;69:1126-30. [DOI: 10.1016/j.recesp.2016.05.037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
51 Lang S, Boccara F, Mary-krause M, Cohen A. Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries. Archives of Cardiovascular Diseases 2015;108:206-15. [DOI: 10.1016/j.acvd.2015.01.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
52 Carballo D, Delhumeau C, Carballo S, Bähler C, Radovanovic D, Hirschel B, Clerc O, Bernasconi E, Fasel D, Schmid P, Cusini A, Fehr J, Erne P, Keller PF, Ledergerber B, Calmy A; Swiss HIV Cohort Study and AMIS registry. Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study. AIDS Res Ther 2015;12:4. [PMID: 25705241 DOI: 10.1186/s12981-015-0045-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
53 Bernelli C, Danzi GB, Cerrato E, Pierini S, Ornaghi MG, Botta L, Gentile F, Migliorino GM, Squillace N. Cardiovascular Events Recurrence and Coronary Artery Disease in HIV Patients: The Price We Have to Pay for the Chronicization of the Disease. Can J Cardiol 2020;36:127-34. [PMID: 31813674 DOI: 10.1016/j.cjca.2019.07.636] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Knudsen A, Mathiasen AB, Worck RH, Kastrup J, Gerstoft J, Katzenstein TL, Kjaer A, Lebech AM. Angiographic features and cardiovascular risk factors in human immunodeficiency virus-infected patients with first-time acute coronary syndrome. Am J Cardiol 2013;111:63-7. [PMID: 23040592 DOI: 10.1016/j.amjcard.2012.08.047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
55 Brenner DA, Dela Cruz M, Thomas K, Mccabe JM, Ganz P, Hsue PY, Waldo SW. Emergency medical service utilization and door-to-balloon time for HIV-infected individuals with ST-elevation myocardial infarction. International Journal of Cardiology 2013;168:4808-9. [DOI: 10.1016/j.ijcard.2013.07.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Ogunbayo GO, Ha LD, Ahmad Q, Misumida N, Okwechime R, Elbadawi A, Abdel-Latif A, Elayi CS, Smyth S, Boccara F, Messerli AW. Treatment Bias in Management of HIV Patients Admitted for Acute Myocardial Infarction: Does It Still Exist? J Gen Intern Med 2020;35:57-62. [PMID: 31713036 DOI: 10.1007/s11606-019-05416-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
57 McCutcheon K, Triantafyllis AS, Van den Eynde J, Oosterlinck W, Vachiat A, Tsabedze N, Zachariah D, Manga P, Bennett J. Coronary revascularization in patients with HIV. Trends Cardiovasc Med 2021:S1050-1738(21)00027-X. [PMID: 33626383 DOI: 10.1016/j.tcm.2021.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Ou HT, Chang KC, Li CY, Yang CY, Ko NY. Intensive statin regimens for reducing risk of cardiovascular diseases among human immunodeficiency virus-infected population: A nation-wide longitudinal cohort study 2000-2011. Int J Cardiol 2017;230:592-8. [PMID: 28062146 DOI: 10.1016/j.ijcard.2016.12.050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
59 Alkhalil M, Conlon CP, Ashrafian H, Choudhury RP. Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection. World J Clin Cases 2017; 5(2): 40-45 [PMID: 28255546 DOI: 10.12998/wjcc.v5.i2.40] [Reference Citation Analysis]
60 Boccara F, Cohen A. How to identify HIV-infected individuals at risk for atherosclerotic events? AIDS 2014;28:2153-5. [PMID: 25265079 DOI: 10.1097/QAD.0000000000000416] [Reference Citation Analysis]
61 Postigo A, Díez-Delhoyo F, Devesa C, Bruña V, Clavero-Olmos M, Vicent L, Juárez M, Sousa I, Fernández-Avilés F, Martínez-Sellés M. Clinical profile, anatomical features and long-term outcome of acute coronary syndromes in human immunodeficiency virus-infected patients. Intern Med J 2020;50:1518-23. [PMID: 31908110 DOI: 10.1111/imj.14744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
62 Pinto DSM, da Silva MJLV. Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection. Curr Cardiol Rev 2018;14:25-41. [PMID: 29189172 DOI: 10.2174/1573403X13666171129170046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
63 Vachiat A, Mccutcheon K, Tsabedze N, Zachariah D, Manga P. HIV and Ischemic Heart Disease. Journal of the American College of Cardiology 2017;69:73-82. [DOI: 10.1016/j.jacc.2016.09.979] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 12.4] [Reference Citation Analysis]
64 Hatleberg CI, Ryom L, Sabin C. Cardiovascular risks associated with protease inhibitors for the treatment of HIV. Expert Opin Drug Saf 2021;:1-16. [PMID: 34047238 DOI: 10.1080/14740338.2021.1935863] [Reference Citation Analysis]
65 Boccara F, Miantezila Basilua J, Mary-Krause M, Lang S, Teiger E, Steg PG, Funck-Brentano C, Girard PM, Costagliola D, Cohen A, Guiguet M; on behalf the PACS-HIV investigators (Prognosis of Acute Coronary Syndrome in HIV-infected patients). Statin therapy and low-density lipoprotein cholesterol reduction in HIV-infected individuals after acute coronary syndrome: Results from the PACS-HIV lipids substudy. Am Heart J 2017;183:91-101. [PMID: 27979047 DOI: 10.1016/j.ahj.2016.10.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
66 Rodriguez VJ, Abbamonte JM, Parrish MS, Jones DL, Weiss S, Pallikkuth S, Toborek M, Alcaide ML, Jayaweera D, Pahwa S, Rundek T, Hurwitz BE, Kumar M. Predicting cardiovascular risk using a novel risk score in young and middle-age adults with HIV: associations with biomarkers and carotid atherosclerotic plaque. Int J STD AIDS 2021;:9564624211050335. [PMID: 34727754 DOI: 10.1177/09564624211050335] [Reference Citation Analysis]
67 Marcus JL, Hurley LB, Prasad A, Zaroff J, Klein DB, Horberg MA, Go AS, DeLorenze GN, Quesenberry CP Jr, Sidney S, Lo JC, Silverberg MJ. Recurrence after hospitalization for acute coronary syndrome among HIV-infected and HIV-uninfected individuals. HIV Med 2019;20:19-26. [PMID: 30178911 DOI: 10.1111/hiv.12670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
68 Hatleberg CI, Lundgren JD, Ryom L. Are we successfully managing cardiovascular disease in people living with HIV? Curr Opin HIV AIDS 2017;12:594-603. [PMID: 28832368 DOI: 10.1097/COH.0000000000000417] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
69 Seecheran R, Seecheran V, Persad S, Dookie T, Seecheran NA. Atypical presentation of critical left main disease in an HIV-infected patient. Int Med Case Rep J 2018;11:139-43. [PMID: 29950906 DOI: 10.2147/IMCRJ.S164642] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
70 Duarte H, Matta JR, Muldoon N, Masur H, Hadigan C, Gharib AM. Non-calcified coronary plaque volume inversely related to CD4(+) T-cell count in HIV infection. Antivir Ther 2012;17:763-7. [PMID: 22293714 DOI: 10.3851/IMP1994] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
71 D’Ascenzo F, Cerrato E, Biondi-Zoccai G, Moretti C, Omedè P, Sciuto F, Bollati M, Modena MG, Gaita F, Sheiban I. Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy. Eur Heart J. 2012;33:875-880. [PMID: 22187508 DOI: 10.1093/eurheartj/ehr456] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 6.9] [Reference Citation Analysis]
72 Yannoutsos A, Ghosn J, Blacher J. [Arterial hemodynamic parameters and cardiovascular risk in HIV patients with controlled infection]. Presse Med 2018;47:3-10. [PMID: 29373278 DOI: 10.1016/j.lpm.2017.12.003] [Reference Citation Analysis]
73 Bajdechi M, Mihai C, Scafa-Udriste A, Cherry A, Zamfir D, Dumitru I, Cernat R, Rugina S. Severe Coronary Artery Disease in a Person Living with HIV. Medicina (Kaunas) 2021;57:595. [PMID: 34200527 DOI: 10.3390/medicina57060595] [Reference Citation Analysis]